All Cancer articles – Page 7
-
ResearchMagnetic fields deliver cancer-killing bacteria to tumour’s heart
Guided microbes packed with drugs can reach the parts of cancers that other drugs just can’t reach
-
BusinessAmgen and Advaxis partner on immuno-oncology
Deal covers rights to system for building cancer therapies specific to a patient’s own tumours
-
BusinessCelgene and Jounce team up against cancer
Firms promise next-generation immuno-oncology as existing drugs rack up successes
-
BusinessJuno CAR-T trial suspended after patient deaths
Immunotherapy study restarted with amended pre-treatment protocol
-
BusinessNovartis partners with Xencor for cancer antibodies
Deal deepens Novartis’s focus on immuno-oncology
-
ResearchNanoprobes to guide cancer radiotherapy dosing
Real-time Sers monitoring of radiation treatment in a 3D prostate cancer model
-
BusinessJazz Pharma buy out Celator in $1.5bn deal
Deal centres on promising leukaemia drug fast-tracked by the US Food and Drug Administration
-
BusinessWHO clarifies glyphosate risks
UN and WHO panel conclude the herbicide glyphosate is ‘unlikely’ to cause cancer at realistic exposure levels
-
BusinessCancer deals spread
AbbVie nabs antibody specialist Stemcentrx, while Sanofi pursues Medivation
-
BusinessFDA moves to withdraw swine drug carbadox
Carcinogenic antibiotic has been banned in EU, Canada and Australia for years
-
-
BusinessRoche sketches out Blueprint collaboration
Drug discovery startup will contribute to cancer immunotherapy projects aimed at kinase enzymes
-
Business
Lilly loses UK patent challenge
Allergan’s cancer drug generics do not infringe patents, say UK courts
-
ResearchPopping nanobubbles let surgeons sound out micro-tumours
Technique that can hunt down and destroy individual cancer cells is set to get clinical trial
-
NewsObama kicks off new initiative to cure cancer
White House launches ‘moonshot’ effort to fight cancer and break down ‘silos’
-
Business
AstraZeneca to buy Acerta for blood cancer drug
Deal will strengthen AstraZeneca’s immunotherapy offering
-
Business
BioAtla and Pfizer to collaborate on antibody research
Two-way agreement to share technology and royalties on new cancer drugs
-
-
BusinessViral cancer therapy approved in the US
T-Vec is the first approved oncolytic virus, but its limited treatment scope means it is unlikely to become a blockbuster
-
ResearchOral delivery of anticancer drug
Researchers endeavour to limit drug side effects and injections for cancer patients